| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.42 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |